BMGL
Basel Medical Group Ltd
Price Chart
Latest Quote
$0.58
-0.01 (-1.97%)
Current Price
| Previous Close | $0.59 |
| Open | $0.55 |
| Day High | $0.59 |
| Day Low | $0.54 |
| Volume | 35,102 |
Stock Information
Note: Financial values converted from SGD to USD
| Shares Outstanding | 18.79M |
| Total Debt | $5.06M |
| Cash Equivalents | $7.61M |
| Revenue | $8.80M |
| Net Income | $-8.24M |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Market Cap | $10.94M |
| EPS (TTM) | $-0.44 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $8.55M |
| Sales | $8.80M |
| Income | $-8.24M |
| Book/sh | $0.23 |
| Cash/sh | $0.52 |
| Employees | 82 |
Financial Ratios
| Quick Ratio | 1.22 |
| Current Ratio | 1.31 |
| Debt/Eq | 120.04 |
Returns & Margins
| ROA | -7.65% |
| ROE | -163.64% |
| Gross Margin | 21.18% |
| Operating Margin | -24.88% |
| Profit Margin | -93.67% |
Ownership
| Insider Ownership | 54.32% |
| Institutional Ownership | 0.32% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 0.96 |
| P/B | 2.59 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.59 |
| SMA50 | $0.62 |
| SMA200 | $0.95 |
| RSI | 49.08 |
| ATR | 0.1404 |
| Shares Float | 6.02M |
| Short Float | 0.20% |
| Short Ratio | 0.78 |
| Rel Volume | 0.02 |
Performance History
| Week | +0.74% |
| Month | -11.37% |
| Quarter | -1.31% |
| 6 Months | -23.58% |
| YTD | +1.98% |
| Year | -78.51% |
| 10 Years | -86.89% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.58 | 35,102 |
| 2026-06-17 | $0.59 | 74,800 |
| 2026-06-16 | $0.63 | 73,000 |
| 2026-06-15 | $0.61 | 42,100 |
| 2026-06-12 | $0.59 | 79,600 |
| 2026-06-11 | $0.58 | 74,600 |
| 2026-06-10 | $0.59 | 515,600 |
| 2026-06-09 | $0.64 | 136,700 |
| 2026-06-08 | $0.60 | 529,900 |
| 2026-06-05 | $0.55 | 5,414,400 |
| 2026-06-04 | $0.49 | 1,111,800 |
| 2026-06-03 | $0.66 | 26,949,100 |
| 2026-06-02 | $0.55 | 59,600 |
| 2026-06-01 | $0.59 | 13,200 |
| 2026-05-29 | $0.59 | 17,000 |
| 2026-05-28 | $0.58 | 900 |
| 2026-05-27 | $0.59 | 20,900 |
| 2026-05-26 | $0.58 | 5,100 |
| 2026-05-22 | $0.60 | 10,100 |
| 2026-05-21 | $0.61 | 13,000 |
| 2026-05-20 | $0.64 | 4,900 |
| 2026-05-19 | $0.66 | 15,300 |
| 2026-05-18 | $0.66 | 14,200 |
About Basel Medical Group Ltd
Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, including trauma and sports medicine services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as neurosurgical treatments. It also provides health screening services, mental health, woman's health, and general practice services. In addition, its services include consultation, medical diagnosis, and medical and surgical treatments. The company was incorporated in 2023 and is headquartered in Singapore.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $2,190,105 | $1,755,341 | $1,824,703 | $1,701,271 |
| Cost Of Revenue | $1,992,957 | $1,755,341 | $1,824,703 | $1,701,271 |
| Total Revenue | $8,838,596 | $7,847,747 | $7,575,134 | $8,322,142 |
| Operating Revenue | $8,838,596 | $7,847,747 | $7,575,134 | $8,322,142 |
| Expenses | ||||
| Interest Expense | $159,242 | $137,606 | $186,300 | $250,533 |
| Total Expenses | $10,537,535 | $6,133,807 | $5,955,302 | $6,390,299 |
| Rent Expense Supplemental | $110,151 | $2,483 | $14,989 | $9,829 |
| Other Income Expense | $-6,835,950 | $301,145 | $55,958 | $-10,607 |
| Other Non Operating Income Expenses | $1,244,731 | $301,145 | $55,958 | $-10,607 |
| Net Non Operating Interest Income Expense | $-95,724 | $-137,606 | $44,494 | $-57,904 |
| Interest Expense Non Operating | $159,242 | $137,606 | $186,300 | $250,533 |
| Operating Expense | $8,544,577 | $4,378,466 | $4,130,599 | $4,689,027 |
| Other Operating Expenses | $2,516,706 | $1,165,395 | $1,145,252 | $1,082,574 |
| General And Administrative Expense | $5,105,648 | $2,843,764 | $2,550,342 | $3,156,777 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-8,304,322 | $1,618,439 | $1,392,390 | $1,544,392 |
| Net Interest Income | $-95,724 | $-137,606 | $44,494 | $-57,904 |
| Interest Income | $63,518 | $0 | $230,794 | $192,628 |
| Normalized Income | $-528,774 | $1,618,439 | $1,392,390 | $1,544,392 |
| Net Income From Continuing And Discontinued Operation | $-8,304,322 | $1,618,439 | $1,392,390 | $1,544,392 |
| Net Income Common Stockholders | $-8,304,322 | $1,618,439 | $1,392,390 | $1,544,392 |
| Net Income | $-8,304,322 | $1,618,439 | $1,392,390 | $1,544,392 |
| Net Income Including Noncontrolling Interests | $-8,304,713 | $1,618,439 | $1,392,390 | $1,544,392 |
| Net Income Continuous Operations | $-8,304,713 | $1,618,439 | $1,392,390 | $1,544,392 |
| Pretax Income | $-8,630,613 | $1,877,478 | $1,664,326 | $1,863,332 |
| Special Income Charges | $-8,080,681 | $0 | - | - |
| Interest Income Non Operating | $63,518 | $0 | $230,794 | $192,628 |
| Operating Income | $-1,698,938 | $1,713,940 | $1,619,832 | $1,931,843 |
| Depreciation Amortization Depletion Income Statement | $922,223 | $412,829 | $435,005 | $449,677 |
| Depreciation And Amortization In Income Statement | $922,223 | $412,829 | $435,005 | $449,677 |
| Depreciation Income Statement | $922,223 | $412,829 | $435,005 | $449,677 |
| Gross Profit | $6,845,639 | $6,092,405 | $5,750,431 | $6,620,871 |
| Per Share | ||||
| Diluted EPS | - | $0.09 | $0.08 | $0.10 |
| Basic EPS | - | $0.09 | $0.08 | $0.10 |
| Other | ||||
| Tax Effect Of Unusual Items | $-305,134 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $531,534 | $2,427,914 | $2,285,631 | $2,563,541 |
| Total Unusual Items | $-8,080,681 | $0 | - | - |
| Total Unusual Items Excluding Goodwill | $-8,080,681 | $0 | - | - |
| Reconciled Depreciation | $725,075 | $412,830 | $435,005 | $449,677 |
| EBITDA (Bullshit earnings) | $-7,549,147 | $2,427,914 | $2,285,631 | $2,563,541 |
| EBIT | $-8,471,370 | $2,015,084 | $1,850,626 | $2,113,865 |
| Diluted NI Availto Com Stockholders | $-8,304,322 | $1,618,439 | $1,392,390 | $1,544,392 |
| Minority Interests | $391 | $0 | - | - |
| Tax Provision | $-325,900 | $259,039 | $271,937 | $318,941 |
| Impairment Of Capital Assets | $8,080,681 | $0 | - | - |
| Provision For Doubtful Accounts | $0 | $-43,522 | $0 | - |
| Selling General And Administration | $5,105,648 | $2,843,764 | $2,550,342 | $3,156,777 |
| Rent And Landing Fees | $110,151 | $2,483 | $14,989 | $9,829 |
| Salaries And Wages | $4,995,497 | $2,841,281 | $2,535,353 | $3,146,948 |
| Diluted Average Shares | - | $14,409,638 | $14,409,638 | $12,687,977 |
| Basic Average Shares | - | $14,409,638 | $14,409,638 | $12,687,977 |
Fetched: 2026-06-15
Balance Sheet (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $4,243,373 | $5,904,119 | $4,285,679 | $2,893,290 |
| Total Assets | $14,585,241 | $12,733,688 | $12,009,139 | $13,155,095 |
| Total Non Current Assets | $4,205,306 | $105,391 | $473,434 | $922,610 |
| Non Current Deferred Assets | $37,381 | $60,125 | $21,523 | $3,313 |
| Non Current Deferred Taxes Assets | $37,381 | $60,125 | $21,523 | $3,313 |
| Current Assets | $10,379,935 | $12,628,298 | $11,535,705 | $12,232,486 |
| Current Deferred Assets | $24,827 | $1,239,927 | $0 | - |
| Prepaid Assets | $5,624,402 | $92,458 | $104,458 | $116,523 |
| Inventory | $381,859 | $56,241 | $73,864 | $54,520 |
| Receivables | $1,971,733 | $9,716,292 | $10,406,802 | $10,840,521 |
| Other Receivables | $104,774 | $166,813 | $12,231 | $92,101 |
| Taxes Receivable | $186,929 | $0 | - | - |
| Accounts Receivable | $1,680,030 | $1,306,401 | $1,120,538 | $1,570,758 |
| Allowance For Doubtful Accounts Receivable | $-459,401 | $-359,490 | $-363,841 | $-247,994 |
| Gross Accounts Receivable | $2,139,431 | $1,665,891 | $1,484,379 | $1,818,752 |
| Cash Cash Equivalents And Short Term Investments | $2,377,115 | $1,523,379 | $950,582 | $1,220,921 |
| Cash And Cash Equivalents | $2,377,115 | $1,523,379 | $950,582 | $1,220,921 |
| Cash Financial | $2,377,115 | $1,523,379 | $950,582 | $1,220,921 |
| Debt | ||||
| Total Debt | $3,964,775 | $3,349,462 | $5,631,712 | $7,927,565 |
| Long Term Debt And Capital Lease Obligation | $2,308,608 | $1,236,343 | $2,673,119 | $4,645,686 |
| Current Debt And Capital Lease Obligation | $1,656,167 | $2,113,119 | $2,958,593 | $3,281,878 |
| Current Debt | $47,918 | $2,090,866 | $2,516,631 | $2,833,358 |
| Net Debt | - | $1,803,830 | $4,216,915 | $5,759,601 |
| Long Term Debt | - | $1,236,343 | $2,650,866 | $4,147,165 |
| Other Current Borrowings | - | $2,090,866 | $2,516,631 | $2,833,358 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $10,339,137 | $6,829,570 | $7,723,460 | $10,261,806 |
| Total Non Current Liabilities Net Minority Interest | $2,405,279 | $1,236,343 | $2,673,119 | $4,645,686 |
| Non Current Deferred Liabilities | $96,671 | $0 | - | - |
| Non Current Deferred Taxes Liabilities | $96,671 | $0 | - | - |
| Current Liabilities | $7,933,858 | $5,593,227 | $5,050,341 | $5,616,120 |
| Current Deferred Liabilities | $0 | $346,140 | $371,446 | $304,900 |
| Current Deferred Taxes Liabilities | $0 | $346,140 | $371,446 | $304,900 |
| Payables And Accrued Expenses | $6,265,979 | $3,122,256 | $1,708,590 | $2,017,629 |
| Payables | $5,142,354 | $2,283,000 | $1,552,214 | $1,442,299 |
| Other Payable | $2,185,775 | $218,957 | $325,090 | $343,781 |
| Total Tax Payable | $218,341 | $305,550 | $83,840 | $121,860 |
| Accounts Payable | $1,605,841 | $647,535 | $1,143,284 | $842,488 |
| Equity | ||||
| Common Stock Equity | $4,243,373 | $5,904,119 | $4,285,679 | $2,893,290 |
| Total Equity Gross Minority Interest | $4,246,105 | $5,904,119 | $4,285,679 | $2,893,290 |
| Stockholders Equity | $4,243,373 | $5,904,119 | $4,285,679 | $2,893,290 |
| Gains Losses Not Affecting Retained Earnings | $-19,456,687 | $-19,094,562 | $0 | - |
| Other Equity Adjustments | $-19,094,562 | $-19,094,562 | - | - |
| Retained Earnings | $-3,009,938 | $5,904,112 | $4,285,673 | $2,893,284 |
| Long Term Equity Investment | $38 | $0 | - | - |
| Other | ||||
| Ordinary Shares Number | $14,667,887 | $14,409,638 | $14,409,638 | $14,409,638 |
| Share Issued | $14,667,887 | $14,409,638 | $14,409,638 | $14,409,638 |
| Tangible Book Value | $4,243,373 | $5,904,119 | $4,285,679 | $2,893,290 |
| Invested Capital | $4,291,291 | $9,231,328 | $9,453,176 | $9,873,813 |
| Working Capital | $2,446,077 | $7,035,071 | $6,485,364 | $6,616,366 |
| Capital Lease Obligations | $3,916,857 | $22,253 | $464,215 | $947,042 |
| Total Capitalization | $4,243,373 | $7,140,462 | $6,936,545 | $7,040,455 |
| Minority Interest | $2,732 | $0 | - | - |
| Foreign Currency Translation Adjustments | $-362,124 | $0 | $0 | - |
| Capital Stock | $26,709,997 | $19,094,569 | $6 | $6 |
| Common Stock | $26,709,997 | $19,094,569 | $6 | $6 |
| Long Term Capital Lease Obligation | $2,308,608 | $0 | $22,253 | $498,521 |
| Current Capital Lease Obligation | $1,608,248 | $22,253 | $441,962 | $448,520 |
| Line Of Credit | $47,918 | $0 | - | - |
| Current Provisions | $11,712 | $11,712 | $11,712 | $11,712 |
| Current Accrued Expenses | $1,123,625 | $839,255 | $156,376 | $575,330 |
| Dueto Related Parties Current | $1,132,396 | $1,110,959 | $0 | $134,170 |
| Investments And Advances | $38 | $0 | - | - |
| Investmentsin Associatesat Cost | $38 | $0 | - | - |
| Net PPE | $4,167,926 | $45,265 | $451,911 | $919,297 |
| Accumulated Depreciation | $-5,112,339 | $-2,917,974 | $-2,505,144 | $-2,107,330 |
| Gross PPE | $9,280,265 | $2,963,239 | $2,957,055 | $3,026,627 |
| Other Properties | $8,669,092 | $2,567,963 | $2,567,963 | $2,638,618 |
| Machinery Furniture Equipment | $611,172 | $395,276 | $389,092 | $388,008 |
| Finished Goods | $381,859 | $56,241 | $73,864 | $54,520 |
| Duefrom Related Parties Current | $0 | $8,243,078 | $9,274,032 | $9,177,661 |
Fetched: 2026-06-15
Cash Flow Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-2,824,454 | $1,953,062 | $2,025,258 | $2,111,258 |
| Operating Activities | ||||
| Operating Cash Flow | $-2,482,558 | $1,959,246 | $2,030,069 | $2,180,354 |
| Cash Flow From Continuing Operating Activities | $-2,482,558 | $1,959,246 | $2,030,069 | $2,180,354 |
| Investing Activities | ||||
| Capital Expenditure | $-341,896 | $-6,184 | $-4,811 | $-69,097 |
| Investing Cash Flow | $-6,689,423 | $-6,184 | $-4,811 | $-69,097 |
| Cash Flow From Continuing Investing Activities | $-6,689,423 | $-6,184 | $-4,811 | $-69,097 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $5,987,443 | $0 | - | - |
| Financing Cash Flow | $10,127,920 | $-1,380,265 | $-2,295,598 | $-10,089,559 |
| Cash Flow From Continuing Financing Activities | $10,127,920 | $-1,380,265 | $-2,295,598 | $-10,089,559 |
| Net Other Financing Charges | $7,567,721 | $901,986 | $254 | $-8,482,990 |
| Net Common Stock Issuance | $5,987,443 | $0 | - | - |
| Common Stock Issuance | $5,987,443 | $0 | - | - |
| Other | ||||
| Repayment Of Debt | $-5,882,779 | $-2,282,250 | $-2,295,852 | $-2,412,009 |
| Issuance Of Debt | $2,455,534 | $0 | $0 | $805,440 |
| End Cash Position | $1,868,948 | $1,523,379 | $950,582 | $1,220,921 |
| Beginning Cash Position | $1,197,719 | $950,582 | $1,220,921 | $9,199,223 |
| Effect Of Exchange Rate Changes | $-284,711 | $0 | - | - |
| Changes In Cash | $955,940 | $572,798 | $-270,340 | $-7,978,302 |
| Net Issuance Payments Of Debt | $-3,427,244 | $-2,282,250 | $-2,295,852 | $-1,606,569 |
| Net Short Term Debt Issuance | $47,918 | $0 | - | - |
| Short Term Debt Issuance | $47,918 | $0 | - | - |
| Net Long Term Debt Issuance | $-3,427,244 | $-2,282,250 | $-2,295,852 | $-1,606,569 |
| Long Term Debt Payments | $-5,882,779 | $-2,282,250 | $-2,295,852 | $-2,412,009 |
| Long Term Debt Issuance | $2,455,534 | $0 | $0 | $805,440 |
| Net Business Purchase And Sale | $-6,347,526 | $0 | - | - |
| Purchase Of Business | $-6,347,526 | $0 | - | - |
| Net PPE Purchase And Sale | $-341,896 | $-6,184 | $-4,811 | $-69,097 |
| Purchase Of PPE | $-341,896 | $-6,184 | $-4,811 | $-69,097 |
| Taxes Refund Paid | $-397,976 | $-137,606 | $-223,600 | $-23,468 |
| Interest Paid Cfo | $-125,200 | $-322,948 | $-186,300 | $-250,533 |
| Change In Working Capital | $-3,043,750 | $-3,763 | $223,934 | $63,531 |
| Change In Payables And Accrued Expense | $2,476,104 | $302,708 | $-174,870 | $50,353 |
| Change In Payable | $2,476,104 | $302,708 | $-174,870 | $50,353 |
| Change In Inventory | $-186,781 | $17,623 | $-19,344 | $2,196 |
| Change In Receivables | $-5,333,072 | $-324,094 | $418,148 | $10,982 |
| Other Non Cash Items | $125,200 | $137,606 | $-44,494 | $57,904 |
| Provisionand Write Offof Assets | $170,107 | $-4,351 | $115,847 | $5,055 |
| Asset Impairment Charge | $6,849,592 | $0 | $45,352 | $14,856 |
| Depreciation Amortization Depletion | $725,075 | $412,830 | $435,005 | $449,677 |
| Depreciation And Amortization | $725,075 | $412,830 | $435,005 | $449,677 |
| Depreciation | $725,075 | $412,830 | $435,005 | $449,677 |
| Net Income From Continuing Operations | $-6,785,607 | $1,877,478 | $1,664,326 | $1,863,332 |
Fetched: 2026-06-15